Searchable abstracts of presentations at key conferences in endocrinology

ea0049ep181 | Endocrine tumours and neoplasia | ECE2017

Insulinoma – clinical features and outcome of patients diagnosed at a central hospital

Prokop Joanna , Martins Ana Claudia , Neves Carolina , Sabino Teresa , Bogalho Paula , Nunes Jose Silva , Fonseca Fernando , Agapito Ana

Insulinoma, a rare neuroendocrine tumor (NET), is benign in more than 90% of cases. We present a review of patients diagnosed with insulinoma at our Department.Methods: Retrospective review of clinical records of patients diagnosed with insulinoma between 2011 and 2016.Results: Six female patients were diagnosed with insulinoma (age at presentation 30–66, follow-up: 0.25–3.25 years). Episodes of sweating, palpitations, tr...

ea0049ep841 | Clinical case reports - Pituitary/Adrenal | ECE2017

Effect of the addition of lanreotide autogel to the treatment of an aggressive prolactinoma – a case report

Vilar Lucio , Vilar Clarice , Albuquerque Jose Luciano , Gadelha Patricia , The Ana Carolina , Trovao Erik , Cardoso Izabela , Cardoso Thaise , Lyra Ruy

Case report: A giant prolactinoma (size=5.2×4.1×3.2 cm; PRL=6 400 ng/mL) was diagnosed in an amenorrheic 19-year old girl who presented to the emergency room complaining of headaches and bilateral decrease in visual acuity for 10 days. The patient was started on cabergoline (CAB) in progressive doses up to 3 mg/week. PRL levels decreased from 6 400 to 4 600 ng/dl within 60 days, with improvement of visual complaints and visual fields defects. The dose was subsequentl...

ea0049ep975 | Pituitary - Clinical | ECE2017

The use of increasing doses of cabergoline in the management of cabergoline-resistant prolactinomas

Vilar Lucio , Vilar Clarice , Albuquerque Jose Luciano , Gadelha Patricia , The Ana Carolina , Trovao Erik , Borges Thaise , Cardoso Izabela , Lyra Ruy

Introduction: Dopamine agonists (DA) are the ideal treatment for prolactinomas and cabergoline (CAB) is the drug of choice, for being much more effective and better tolerated than bromocriptine. However, 10-15% of patients with prolactinomas are considered to be resistant to CAB, as they dot not achieve prolactin (PRL) normalization, while in use of conventional doses of this drug.Objective: To evaluate the effiaccy of increasing doses of CAB in prolacti...

ea0049ep1133 | Female Reproduction | ECE2017

Influence of thyroid stimulating hormone (TSH) level in in-vitro fertilization (IVF) success

Faria Carolina , Gomes Ana , Nunes Joaquim , Sousa Sandra , Ana Aguiar , Catia Rodrigues , Joaquim Sampaio , Carlos Calhaz-Jorge

Introduction: Prevalence of hypothyroidism is 2–5% in women in the reprodutive age group. Hypothyroidism can affect fertility due to anovulatory cycles, luteal phase defects, hyperprolactinemia and sex hormones imbalance. Some data also report that TSH levels are inversely proportional to the fertilization rate at ART (assisted reproductive technologies).Objective: To evaluate if a relationship exists between pregnancy rates in women undergoing ...

ea0041ep510 | Diabetes complications | ECE2016

Stroke recurrence (but not mortality) is higher among diabetic and prediabetic patients

Silva-Fernandez Julia , Garcia-Ruiz Rafael , Garcia-Ruiz Rosa M , Carmen Blanco-Valero M , Gonzalez-Pereira Carolina

Introduction: Diabetes Mellitus (DM) and prediabetic states (pre-DM) are well known risk factors for stroke. Admission blood glucose level and its control during hospital stay, help predicting arterial recanalization after thrombolysis and middle and long term prognosis. We analysed recurrence, mortality and nosocomial infectious complications in DM, pre-DM and patients without previous or newly diagnosed DM or pre-DM.Methods: Descriptive analysis in con...

ea0037gp.11.04 | Calcium, Vitamin D and Bone (1) | ECE2015

Secondary hyperparathyroidism in HIV patients and its relation to cardiovascular risk factors

Blanco Manuel Cayon , Garcia-Figueras Mateos Carolina , Pardo Rosa Marquez , Herrera Patricia Bancalero , Pernia Alberto Terron , Cortes Salvador Perez

Rationale: Low level of vitamin D can results in secondary hyperparathyroidism (SH) that has been linked to increased cardiovascular risk in general population. However, the spectrum of cardiovascular risk associated with SH in HIV-infected adults remains uncertain. Our main aim was to determine its potential association with different markers of cardiovascular risk in HIV-infected adults.Methods: Cross-sectional study. Clinical data related to obesity, ...

ea0037ep88 | Adrenal cortex | ECE2015

A single-centre 10-years experience with pasireotide in Cushing's disease: patients characteristics and outcome

Trementino Laura , Michetti Grazia , Angeletti Alessia , Marcelli Giorgia , Concettoni Carolina , Cardinaletti Marina , Polenta Barbara , Boscaro Marco , Arnaldi Giorgio

Introduction: Pasireotide is the first pituitary-directed drug approved for Cushing’s disease (CD). We report our 10-years experience with pasireotide in CD reviewing and analysing data about all the patients treated with pasireotide at our referral centre both in randomised trials and in clinical practice.Patients and methods: Twenty active CD patients were treated. Fourteen patients were treated with pasireotide in randomised trials and six patien...

ea0037ep348 | Diabetes (pathiophysiology & epitemiology) | ECE2015

Abnormalities in glucose metabolism are present in HCV/HIV co-infected patients with severe liver fibrosis even in the absence of diabetes

Blanco Manuel Cayon , Mateos Carolina Garcia-Figueras , Nieto Gloria Baena , Herrera Patricia Bancalero , Cortes Salvador Perez , Pernia Alberto Terron

Rationale: Type 2 diabetes mellitus (T2DM) is a well known independent prognosis factor associated with cirrhosis. Nevertheless, few studies are focused on the association between glucose metabolism and liver fibrosis in HCV/HIV patients and their conclusions are contradictory. The aim of our study was to investigate the relationship between glucose homeostasis and liver fibrosis in these patients.Methods: In a cross-sectional study, we compared prevalen...

ea0037ep388 | Diabetes (pathiophysiology & epitemiology) | ECE2015

Contribution of glucose variability to HbA1c levels in patients with type 1 diabetes

Cardoso Luis , Batista Carla , Rodrigues Dircea , Moreno Carolina , Guelho Daniela , Vicente Nuno , Balsa Margarida , Martins Diana , Oliveira Diana , Carrilho Francisco

Background: Optimal management of type 1 diabetes requires full understanding of the relationships between the triad: HbA1c, fasting plasma glucose, and glucose variability (GV). As GV may contribute to HbA1c we assessed the influence of GV in HbA1c levels.Research design and methods: We retrospectively analysed 9393 h of continuous glucose monitorings (CGMs) from 61 patients with type 1 diabetes. Periods of 24 h with missing values were excluded. We cal...

ea0037ep819 | Pituitary: clinical | ECE2015

Endocrine manifestations of Langerhans cell histiocytosis

Cardoso Luis , Gomes Leonor , Rodrigues Dircea , Moreno Carolina , Guelho Daniela , Vicente Nuno , Balsa Margarida , Martins Diana , Oliveira Diana , Carrilho Francisco

Introduction: Langerhans cell histiocytosis (LCH) is a rare disorder characterized by proliferation/accumulation of cells phenotypically similar to skin Langerhans cells. Clinical presentation and aggressiveness are very heterogeneous, from benign to disseminated forms that cause significant morbi-mortality, particularly endocrine failures.Case 1: A 15-year-old Caucasian woman presented with a 14-month history of headaches, secondary amenorrhea. She repo...